Radiation Oncology (Jun 2022)

High-dose stereotactic radiotherapy boost in the treatment of squamous cell carcinoma of the head and neck region

  • Paweł Polanowski,
  • Agnieszka Pietruszka,
  • Dorota Księżniak-Baran,
  • Aleksandra Grządziel,
  • Ewa Chmielik,
  • Marek Kentnowski,
  • Natalia Amrogowicz,
  • Krzysztof Składowski,
  • Katarzyna Polanowska

DOI
https://doi.org/10.1186/s13014-022-02069-4
Journal volume & issue
Vol. 17, no. 1
pp. 1 – 6

Abstract

Read online

Abstract Background Surgical resection with adjuvant concurrent radiochemotherapy is the standard of care for stage III–IV oral cavity cancer. In some cases, the dynamic course of the disease is out of the prepared schedule of treatment. In that event, a stereotactic radiosurgery boost might be the only chance for disease control. Case presentation Here, we present a case study of a patient with oral cancer who underwent surgery. During adjuvant radiotherapy, a metastatic cervical lymph node was diagnosed based on fine-needle aspiration biopsy. To increase the total dose to the metastatic tumor, a stereotactic radiosurgery boost of 1 × 18 Gy was performed two days after the last fraction of conventional radiotherapy. The early and late tolerance of this treatment were positive. During the 18-month follow-up, locoregional recurrence was not detected. The patient died due to secondary malignancy. Conclusions This paper shows that a stereotactic radiosurgery boost added to adjuvant conventional radiotherapy is an effective approach permitting the maintenance of good local control in well-selected patients.

Keywords